Topics
Glioblastoma | Treatment | Targeted therapy | Defactinib
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Defactinib
Del
Valle MM, Colon EM, Kettimuthu K, Maner-Smith K, Olson JJ,
Kucheryavykh LY.
Window
of opportunity study measuring defactinib and avutometinib
delivery in glioblastomas.
Cancer
Chemother Pharmacol.
2026 Mar 6;96(1):22. doi:
10.1007/s00280-026-04870-4. PMID:
41790275. Clinical
trials.gov ID:
NCT05798507.
ˍ